BAYZF
Stock Details
BAYZF is Bayer Aktiengesellschaft's stock. Stock exchange Other OTC (Currency USD). Average price in 50 days is 61.55$. Average daily volumn in 3 months 18.23k. Market cap 60.52B
Stock symbol : BAYZF. Exchange : Other OTC. Currency : USD Lastest price : 61.60$. Total volume : 78.00. Market state POST Click reload if you want to check the lastest price on market!!!
Bayer Aktiengesellschaft (BAYZF)
Last Price
61.60$Change
0.00Volume
78.00
| Previous Close | 61.60 |
| Open | 61.60 |
| Day Range | 61.60-61.60 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Volume | 78 |
| Average Volume | 18.23k |
| Market Cap | 60.52B |
| Beta | 1.16 |
| 52 Week Range | 45.99-74.34 |
| Trailing P/E | 13.19 |
| Foward P/E | N/A |
| Dividend (Yield %) | 4.27% |
| Ex-Dividend Date | 2023-05-02 |
Financial Details
Organization
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescr... iption over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Market Cap:
60.52BRevenue:
50.74BTotal Assets:
124.88BTotal Cash:
5.17B
News about "Bayer Aktiengesellschaft"
Bayer Aktiengesellschaft 2022 Q4 - Results - Earnings Call Presentation
Source from : Seeking Alpha - 22 days ago
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»
Bayer plans to spend $1 billion on US pharma R&D in 2023-US pharma head
Source from : Reuters on MSN - 13 days ago
Bayer AG plans to spend $1 billion on drug research and development in the U.S. this year as it works to double its sales in the country by the end of the decade, Bayer's top U.S. pharmaceutical ...See details»
Bayer AG: Potential To Double Over 12-18 Months
Source from : Seeking Alpha - 28 days ago
Bayer AG is a $50-billion multinational life sciences conglomerate based in Germany. The company is trading at a discount of at least 20% compared to its peers as well as to its historical multiples.See details»
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Value Stock
Source from : Yahoo - 1 month ago
Bayer Aktiengesellschaft (BAYRY) Headquartered in Leverkusen, Germany, Bayer AG is a life science company with core competencies in the areas of health care and agriculture. Want the latest ...See details»
Bayer AG
Source from : Newsweek - 1 month ago
Bayer and Monsanto assume no obligation to update the information in this communication, except as otherwise required by law. Readers are cautioned not to place undue reliance on these forward ...See details»
Bayer combines ag expertise with Microsoft’s cloud solutions
Source from : Fresh Fruit Portal - 2 days ago
Bayern launched its AgPowered Services which provide cloud-based solutions to work with the Microsoft Azure Data Manager for agriculture.See details»
Unternehmensdaten
Source from : OnVista - 6 days ago
Die Bayer AG ist ein international tätiger Chemie- und Pharmakonzern, der in den Geschäftsfeldern Gesundheit (Bayer Health Care), Agrarwirtschaft (Bayer Crop Science) und hochwertigen ...See details»
A Piece Of The Puzzle Missing From Bayer Aktiengesellschaft's (ETR:BAYN) Share Price
Source from : Yahoo Finance - 19 days ago
When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") above 16x, you may consider Bayer Aktiengesellschaft (ETR:BAYN) as an attractive investment with its 13.5x P ...See details»
Bayer Aktiengesellschaft (BAYN.DE)
Source from : Yahoo Finanzen - 1 month ago
Bayer Aktiengesellschaft / Schlagwort(e): Personalie Bayer Aktiengesellschaft: William N. Anderson folgt auf Werner Baumann als Vorstandsvorsitzender der Bayer AG 08.02.2023 / 17:14 CET/CEST ...See details»
Bayer's (BAYRY) Q4 Earnings and Revenues Top, Outlook Weak
Source from : Nasdaq - 22 days ago
Bayer AG BAYRY reported fourth-quarter 2022 core earnings of 34 cents per American Depositary Receipt (“ADR”), which beat the Zacks Consensus Estimate of 32 cents and our estimate of 28 cents.See details»
Bayer warns on 2023 earnings as inflation remains high, after disappointing quarter
Source from : MarketWatch - 22 days ago
Bayer AG on Tuesday reported net profit for the fourth quarter of 2022 that missed consensus expectations despite higher sales, and said it expects earnings for 2023 to be lower than the prior ...See details»
Client Profile: Bayer AG
Source from : OpenSecrets.org - 1 month ago
A special interest's lobbying activity may go up or down over time, depending on how much attention the federal government is giving their issues. Particularly active clients often retain multiple ...See details»
Bayer AG PK (BAYRY) Earnings Dates & Reports
Source from : Investing - 20 days ago
View upcoming earnings forecasts and in-depth analysis of company forecasts.See details»
Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG
Source from : Yahoo News UK - 1 month ago
Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG 08-Feb-2023 / 17:14 CET/CEST Disclosure of an inside information acc. to ...See details»